| 000 | 01718 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250514002143.0 | ||
| 264 | 0 | _c20010705 | |
| 008 | 200107s 0 0 eng d | ||
| 022 | _a1525-4135 | ||
| 024 | 7 |
_a10.1097/00126334-200105010-00005 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aArpadi, S M | |
| 245 | 0 | 0 |
_aLipodystrophy in HIV-infected children is associated with high viral load and low CD4+ -lymphocyte count and CD4+ -lymphocyte percentage at baseline and use of protease inhibitors and stavudine. _h[electronic resource] |
| 260 |
_bJournal of acquired immune deficiency syndromes (1999) _cMay 2001 |
||
| 300 |
_a30-4 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 |
_aAbsorptiometry, Photon _xmethods |
| 650 | 0 | 4 |
_aAnti-HIV Agents _xadverse effects |
| 650 | 0 | 4 | _aBody Composition |
| 650 | 0 | 4 | _aCD4 Lymphocyte Count |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHIV Infections _xcomplications |
| 650 | 0 | 4 |
_aHIV Protease Inhibitors _xadverse effects |
| 650 | 0 | 4 |
_aHIV-1 _xphysiology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLipodystrophy _xetiology |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aReverse Transcriptase Inhibitors _xadverse effects |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 |
_aStavudine _xadverse effects |
| 650 | 0 | 4 | _aViral Load |
| 700 | 1 | _aCuff, P A | |
| 700 | 1 | _aHorlick, M | |
| 700 | 1 | _aWang, J | |
| 700 | 1 | _aKotler, D P | |
| 773 | 0 |
_tJournal of acquired immune deficiency syndromes (1999) _gvol. 27 _gno. 1 _gp. 30-4 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1097/00126334-200105010-00005 _zAvailable from publisher's website |
| 999 |
_c11334908 _d11334908 |
||